Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 25 Nov 2024
New treatments reshape metastatic and muscle-invasive bladder cancer therapy
Read Full News1.
Dasatinib Fails to Improve Outcomes in CBF-AML
2.
Millions of men could benefit from faster scan to diagnose prostate cancer
3.
WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction
4.
Adopted cancer cells and the effects of their presence.
5.
Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.
1.
Unveiling the Hidden Benefits of Lymphedema Treatment
2.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
3.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
4.
Nuclear Medicine's Role in Battling Women's Cancers
5.
Lactic Acid-Linked lncRNAs in Wilms Tumor: Decoding the Tumor Microenvironment & Prognosis
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
3.
Efficient Management of First line ALK-rearranged NSCLC - Part II
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge